Table 3. Present rates for selected melanoma markers proposed in the literature.
Protein | Unfractionated approach | Fractionated approach |
---|---|---|
S100B | 70% | 100% |
ICAM | 43,3% | 100% |
NDKA (NM23) | 46,7% | 83.3% |
MUC18 (MCAM) | 40% | 100% |
PMEL (GP100) | 46,7% | 58.3% |
MMP-9 | 0% | 50% |
CD44 | 3,3% | 25% |
Tyrosinase | 3,3% | 16.7% |
AP-2 | 0% | 8.3% |
MITF | 0% | 8.3% |